Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to -$62.8 million.

  • Kiniksa Pharmaceuticals International's Cash from Investing Activities fell 88857.91% to -$62.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$52.9 million, marking a year-over-year decrease of 2439.37%. This contributed to the annual value of $37.7 million for FY2024, which is 22745.54% up from last year.
  • Kiniksa Pharmaceuticals International's Cash from Investing Activities amounted to -$62.8 million in Q3 2025, which was down 88857.91% from -$3.9 million recorded in Q2 2025.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Cash from Investing Activities registered a high of $86.0 million during Q2 2021, and its lowest value of -$62.8 million during Q3 2025.
  • For the 5-year period, Kiniksa Pharmaceuticals International's Cash from Investing Activities averaged around $552263.2, with its median value being -$6.3 million (2024).
  • Per our database at Business Quant, Kiniksa Pharmaceuticals International's Cash from Investing Activities surged by 53838.46% in 2024 and then crashed by 88857.91% in 2025.
  • Quarter analysis of 5 years shows Kiniksa Pharmaceuticals International's Cash from Investing Activities stood at -$50.0 million in 2021, then increased by 14.75% to -$42.7 million in 2022, then soared by 65.09% to -$14.9 million in 2023, then skyrocketed by 538.38% to $65.3 million in 2024, then crashed by 196.11% to -$62.8 million in 2025.
  • Its Cash from Investing Activities was -$62.8 million in Q3 2025, compared to -$3.9 million in Q2 2025 and -$51.5 million in Q1 2025.